During the past decade, Toulouse UH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Toulouse UH" are "Major Depressive Disorder, Recurrent, Unspecified" (1 trials) and "Septic Shock" (1 trials). Many other conditions were trialed in "Toulouse UH" in a lesser frequency.

Most popular intervention types in "Toulouse UH" are "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deep brain stimulation of nucleus accumbens" (1 trials) and "early septic shock" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toulouse UH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Toulouse UH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Toulouse UH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toulouse UH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".